| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
56.780 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
56.780 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
56.780 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
56.780 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
56.780 |
Evidence |
|
| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
56.780 |
Evidence |
|
| ZBTB7A |
ZBTB7A, FBI1, LRF, ZBTB7: Zinc finger and BTB domain-containing protein 7A |
JUN |
JUN: Transcription factor AP-1 |
56.780 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
56.780 |
Evidence |
|
| KNG1 |
IPI00215894 |
C6 |
C6: Complement component C6 precursor |
56.740 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
56.720 |
Evidence |
|
| POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
56.670 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
56.490 |
Evidence |
|
| PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
56.310 |
Evidence |
|
| SYNJ2 |
SYNJ2, KIAA0348: Synaptojanin-2 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
56.300 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
56.220 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
56.220 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
56.220 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
56.220 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
56.220 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
56.220 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
56.220 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
DOK1 |
DOK1: Docking protein 1 |
56.220 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
56.200 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
GRB10 |
IPI00012752 |
56.200 |
Evidence |
|
| GRB10 |
IPI00012752 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
56.200 |
Evidence |
|
-